Markets.com Logo

ENLV

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    293.584$
  • Previous Close
    307.3146$
  • 52 Week Change
    469.70$
  • Day Range
    -13.73$
  • 52 Week High/Low
    213.2$ - 682.9$
  • Dividend Per Share
    --
  • Market cap
    701 M$
  • EPS
    -0.31
  • Beta
    1.521
  • Volume
    --

About

ENLV.TA is the stock ticker symbol for Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company. The company is listed on the Tel Aviv Stock Exchange (TASE), which is indicated by the ".TA" suffix. Enlivex focuses on developing allogeneic drug products for immune and cell-mediated diseases.
ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

ETH Price Prediction 2026: Ethereum Sees $14.5B in 24-Hour Volume, What’s Next for ETHUSD?

Ghko B|--
Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Mag 7 stocks analysis: What’s going on with Nvidia, Microsoft, Meta and the Rest?

Ghko B|--

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Howard Marks on Market Cycles, Value Investing Logic, and Current Economic Shifts

Sophia Claire|--
EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

Ghko B|--

Factors

ENLV.TA's price is influenced by various factors: Clinical Trial Results: Positive data boosts investor confidence, driving price up; negative data leads to price decline. Regulatory Approvals: FDA or EMA approval significantly impacts value; delays or rejections negatively affect stock price. Market Sentiment: General biotech optimism or pessimism impacts ENLV.TA; investor risk appetite affects demand. Competition: Competing therapies impact ENLV.TA's market potential; successful competitor drugs lower ENLV.TA's value. Financial Performance: Revenue, profitability, and cash flow influence investor perception; poor financial results decrease stock price. Partnerships/Acquisitions: Strategic alliances or acquisitions can boost investor confidence and stock value. Economic Conditions: Broader economic trends impact investment in biotech; recessionary periods can lower stock prices.

People Also Watch

Latest news

Egypt Gold Price Update: How Much Does 21K Gold Cost Per Gram Right Now?

Egypt Gold Price Update: How Much Does 21K Gold Cost Per Gram Right Now?

Ghko B|--
Gold Price Today, April 28: XAUUSD Hits $4,702 as Safe-Haven Demand Remains Strong Amid Geopolitical Tensions

Gold Price Today, April 28: XAUUSD Hits $4,702 as Safe-Haven Demand Remains Strong Amid Geopolitical Tensions

Ghko B|--
South Africa Exchange Control Revamp 2026: Boosting GDP Growth with Billions in New Investment

South Africa Exchange Control Revamp 2026: Boosting GDP Growth with Billions in New Investment

Ghko B|--

Latest Education Articles

How to Open a Brokerage Account: A Step-by-Step Guide for New Traders and Investors

How to Open a Brokerage Account: A Step-by-Step Guide for New Traders and Investors

Julian Parker|--
Pre-Market Trading Explained: How It Works, Key Risks, Strategies, and What Traders Should Know

Pre-Market Trading Explained: How It Works, Key Risks, Strategies, and What Traders Should Know

Julian Parker|--
What Are Stock Buybacks and How Do They Work?

What Are Stock Buybacks and How Do They Work?

Julian Parker|--
Recommended Topics